Tag: India pharmaceutical

China vs India Pharmaceutical Manufacturing: Risks and FDA Monitoring Explained
4, February, 2026

China vs India Pharmaceutical Manufacturing: Risks and FDA Monitoring Explained

China and India dominate global pharmaceutical manufacturing but face different FDA monitoring challenges. China's high-volume production has quality risks, while India's compliance strengths come with API dependency issues. Learn how these factors impact drug safety and supply chains.

Read more